Who Owns Eupraxia Pharmaceuticals Inc. (EPRX)?Hedge Fund & Institutional Holders
Institutional Holders
43
as of Q4 2025
Total Institutional Value
$1.0192000100000009e+145T
% of Float Held
—
QoQ Change in Holders
+10 / -6
Price History
EPRX — Biggest New Institutional Buyers This Quarter
| Fund | Action | Shares Added | Value Added |
|---|---|---|---|
| Point72 Asset Management, L.P. | New Position | +712K | +$5.0B |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | New Position | +278K | +$2.0B |
| SCOTIA CAPITAL INC. | Increased | +8K | +$1.7B |
| SummitTX Capital, L.P. | New Position | +176K | +$1.3B |
| UBS Group AG | Increased | +124K | +$1.1B |
| BANK OF AMERICA CORP /DE/ | Increased | +208K | +$999.7M |
| GUARDIAN WEALTH ADVISORS, LLC / NC | New Position | +10K | +$75.0M |
| Ikarian Capital, LLC | New Position | +610K | +$4.6M |
| Squadron Capital Management LLC | New Position | +500K | +$3.8M |
| MARSHALL WACE, LLP | New Position | +158K | +$1.0M |
| BOOTHBAY FUND MANAGEMENT, LLC | New Position | +156K | +$1.0M |
| ACADIAN ASSET MANAGEMENT LLC | Increased | +134K | +$875K |
| INGALLS & SNYDER LLC | Increased | +18K | +$235K |
| TD Waterhouse Canada Inc. | New Position | +10K | +$71K |
| GEODE CAPITAL MANAGEMENT, LLC | New Position | +14K | +$0 |
EPRX — Institutions Reducing or Closing Positions
| Fund | Action | Shares Sold | Value Sold |
|---|---|---|---|
| Logos Global Management LP | Closed Position | -900K | -$5.3B |
| Ally Bridge Group (NY) LLC | Decreased | -517K | -$2.4B |
| ROYAL BANK OF CANADA | Decreased | -233K | -$1.5B |
| Alyeska Investment Group, L.P. | Closed Position | -250K | -$1.5B |
| Guardian Partners Inc. | Closed Position | -24K | -$147.4M |
| JPMORGAN CHASE & CO | Closed Position | -16K | -$97.0M |
| Integrated Wealth Concepts LLC | Closed Position | -12K | -$70.8M |
| Tower Research Capital LLC (TRC) | Closed Position | -9 | -$53K |
| NATIONAL BANK OF CANADA /FI/ | Decreased | -296 | -$5K |
| Beutel, Goodman & Co Ltd. | Decreased | -350K | -$-4.0M |
Top Institutional Holders(Q4 2025)
EPRX Institutional Ownership History
| Quarter | Holders | Total Value | Change |
|---|---|---|---|
| Q4 2025 | 35 | $58.3B | +9 |
| Q3 2025 | 26 | $50.5B | +14 |
| Q2 2025 | 12 | $3.3B | +1 |
| Q1 2025 | 11 | $6.7B | +1 |
| Q4 2024 | 10 | $5.6B | +1 |
| Q3 2024 | 9 | $4.5B | +0 |
| Q2 2024 | 9 | $4.4B | — |
Similar Stocks by Institutional Ownership
As of Q4 2025, 43 institutional investors hold EPRX (Eupraxia Pharmaceuticals Inc.). The largest holder is Vivo Capital, LLC with $10.2B in shares. This quarter, 10 institutions opened new positions and 6 closed their positions.
Frequently Asked Questions
How many hedge funds own EPRX?
As of Q4 2025, 43 institutional investors report holding EPRX (Eupraxia Pharmaceuticals Inc.) in their 13F filings.
Who is the largest institutional holder of EPRX?
The largest institutional holder of EPRX is Vivo Capital, LLC with $10.2B in shares.
Is institutional ownership of EPRX increasing or decreasing?
This quarter, 10 institutions opened new positions in EPRX and 6 closed their positions.